In the few years, and especially since the U.S. government passed the 2018 Farm Bill, CBD products have exploded onto the global marketplace. Now that any kind of consumer product imaginable has been marketed with CBD additives—including things like sportswear, pillows, toothpaste, and even hand sanitizer—manufacturers are exploring less prominent cannabinoids to isolate and market in consumer products.
In this FREE Harris Bricken webinar tomorrow at 12pm PST our cannabis and hemp attorneys, Daniel Shortt (Seattle, WA), Griffen Thorne (Los Angeles, CA), Nathalie Bougenies (Portland, OR) and Vince Sliwoski (Portland, OR) will discuss the latest trends in the developing cannabinoid market, including CBG, CBN, and others. We will also examine the approach to regulating hemp, marijuana, and their cannabinoids within state, federal and international frameworks. Domestically, we will look closely at the FDA, to highlight where we think states will go with regulating “new cannabinoids”. And finally, we will discuss intellectual property and a host of other commercial contract issues that are critical for cannabinoid product marketers, manufacturers, and sellers.
Don’t forget to tune in to learn about the law surrounding new trends in cannabinoids and cannabinoid products! Register HERE and we look forward to seeing you tomorrow.